- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Carcinoma
Total 76446 results
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Malignant Ovarian Endometrioid Tumor | Ovarian High Grade Serous Adenocarcinoma | Platinum-Sensitive Ovarian Carcinoma | Fallopian Tube High Grade Serous Adenocarcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Urothelial Carcinoma | Recurrent Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Advanced Urothelial CarcinomaUnited States
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen Research & Development, LLCActive, not recruitingClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Bladder Urothelial Carcinoma | Metastatic Kidney Carcinoma | Malignant Urinary System NeoplasmUnited States
-
Mansoura UniversityUnknownCystoscopy | Bladder Urothelial Carcinoma | Bladder Neoplasm | TURBTEgypt
-
Accelerated Community Oncology Research NetworkGenentech, Inc.; Celgene CorporationCompletedEpithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States
-
University Health Network, TorontoBladder Cancer CanadaRecruitingBladder Cancer | Bladder Urothelial CarcinomaCanada
-
SCRI Development Innovations, LLCCelgeneTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingProstate Cancer | Urothelial Carcinoma | Stage IV Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Platinum-Resistant Urothelial CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial CarcinomaUnited States
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Varian, a Siemens Healthineers CompanyRigshospitalet, Denmark; Herlev HospitalRecruitingMuscle-Invasive Bladder CarcinomaDenmark
-
ElyptaLund UniversityRecruitingMuscle-Invasive Bladder CarcinomaSweden, Denmark, Italy
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital...Not yet recruitingMuscle-Invasive Bladder Carcinoma
-
IRCCS San RaffaeleBristol-Myers SquibbRecruiting
-
C2i GenomicsFox Chase Cancer Center; Baylor College of Medicine; New York University; The Cleveland... and other collaboratorsTerminated
-
Emory UniversityTerminatedBladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
Seoul National University HospitalPharos iBio Co., Ltd.RecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-refractory Ovarian CarcinomaKorea, Republic of
-
Fidia Farmaceutici s.p.a.RecruitingBladder Carcinoma in Situ (CIS)United States, Spain, Italy, France, Poland
-
Case Comprehensive Cancer CenterPfizerTerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditionsUnited States, Finland
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedBladder Carcinoma | Small Cell Carcinoma | Lung NeoplasmCanada
-
University of MiamiTerminatedBladder Cancer | Bladder Carcinoma | Muscle Invasive Bladder Carcinoma | Transition Cell CancerUnited States
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier TherapeuticsTerminatedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedTransitional Cell Carcinoma | Bladder CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Astellas Pharma US, Inc.; Seagen Inc.RecruitingUrothelial CarcinomaUnited States
-
PfizerMerck KGaA, Darmstadt, GermanyActive, not recruiting
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedUrothelial CarcinomaNetherlands
-
DendreonTerminatedUrothelial CarcinomaUnited States
-
University Hospital Southampton NHS Foundation...Roche Pharma AG; Cancer Research UKRecruitingSquamous Cell Carcinoma | Urinary Tract CancerUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterImmunoGen, Inc.; Clovis Oncology, Inc.Active, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Folate Receptor Alpha Positive | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Recurrent Uterine Serous Carcinoma | Recurrent Uterine Carcinosarcoma | Platinum...United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States
-
Masonic Cancer Center, University of MinnesotaIncyte CorporationCompletedOvarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Bernie EiglLady Davis Institute; Vancouver Prostate Centre; Bladder Cancer CanadaRecruitingMetastatic Urothelial Carcinoma | Metastatic Bladder CancerCanada
-
University of Texas Southwestern Medical CenterRecruitingUrothelial Cancer of Renal Pelvis | Urothelial Carcinoma UreterUnited States
-
University of California, DavisNational Cancer Institute (NCI)RecruitingGastric Carcinoma | Lung Carcinoma | Malignant Neoplasm | Bladder Carcinoma | Liver and Intrahepatic Bile Duct CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ExelixisActive, not recruitingRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Malignant Neoplasms of Urinary Tract | Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Metastatic Squamous Cell Carcinoma in... and other conditionsCanada
-
University of WashingtonGlaxoSmithKlineRecruitingAnatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic... and other conditionsUnited States
-
Biotech Pharmaceutical Co., Ltd.UnknownEsophageal Squamous Cell CarcinomasChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Biliary Tract Carcinoma | Advanced Primary Liver CancerChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedTransitional Cell Carcinoma | Bladder CancerItaly
-
University of British ColumbiaCanadian Urologic Oncology GroupCompletedTransitional Cell Carcinoma | Bladder CancerCanada
-
Tianjin Medical University Second HospitalRecruitingHigh-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Tianjin Medical University Second HospitalRecruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | High-RiskChina
-
Fox Chase Cancer CenterTemple UniversityActive, not recruitingUrothelial CarcinomaUnited States